863017: Bard UltraClip II Breast Tissue Marker, Titanium PVA Ribbon 17G x 10cm

Sign in to add this product to your favorites!
| Price: | $299.00 per box of 5 |
|---|---|
| In Stock: | 0 box of 5 |
| Expiration: | In-Date |
We currently do not have this item in stock, but we can email you as soon as it is available.
Related Items
040316 - Size: 17G $249.00 per box of 10 Carbon Medical BiomarC Biopsy Tissue Marker for Mammotome Elite/Core, Tribell, 1mm x 5mm, Rigid SS 17G Needle Exp: 02-2029 Units in stock: 1 box of 10 | Order Qty |
040316 - Size: 17G $50.00 EACH Carbon Medical BiomarC Biopsy Tissue Marker for Mammotome Elite/Core, Tribell, 1mm x 5mm, Rigid SS 17G Needle Exp: 02-2029 Units in stock: 5 | Order Qty |
UCTW17-SD - Size: 17G $249.99 per box of 5 Bard UltraCor Twirl Breast Tissue Marker, 17G x 10cm (EXPIRES 8/28/26) Exp: 08-2026 Units in stock: 4 box of 5 | Order Qty |
Additional Details
BD Bard UltraClip™ II Breast Tissue Markers
The UltraClip™ II Breast Tissue Markers are designed to allow a breast lesion to be marked so the site can be accurately identified at a future date. The marker family is designed for use with ultrasound, MRI or stereotactic imaging guidance.
AccessGUDID Info
- FDA Product Code: NEU
- FDA Product Code Name: MARKER, RADIOGRAPHIC, IMPLANTABLE
- FDA Product Code: GDW
- FDA Product Code Name: Staple, Implantable
- GMDN Term Code: 40808
- GMDN Term Name: Radiological image marker, implantable
- GMDN Term Description: A device intended to be implanted within the body, either temporarily or permanently, to create identifying marks that can be seen on radiographic film or digital images. It is typically in the form of a wire, needle, bead, clip, stent-like tube, washer or fluid, and used to locate and delineate a tumour, lesion, or other site of interest. It is made from materials compatible with the imaging system with which it is intended to be used [e.g., magnetic resonance imaging (MRI), x-ray, or nuclear medicine]; it may be intended for use during radiotherapy procedures.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE